“…They may achieve this by inhibition of COX-1/COX-2 enzymes (Seeram et al, 2003;Santangelo et al, 2007), repression of nitric oxide (NO) production (Lyu and Park, 2005;Santangelo et al, 2007), varying degrees of regulation of the expression of proinflammatory cytokines like IL-6 and IL-12 (Ichikawa et al, 2004;Santangelo et al, 2007) or by the inhibition of nuclear factor kappa B (NF-κB) and Activator Protein-1 (AP-1) mediated gene activation (Ichikawa et al, 2004;Ahmad et al, 2000;Zaveri, 2006). Catechins inhibit the activation of genes in response to ROS; for example, in the case of NF-κB by either scavenging ROS or by reducing the degradation of the IκB, the inhibitory protein for NF-κB (Nam et al, 2001;Ichikawa et al, 2004;Zaveri, 2006).…”